Online Program Home
My Program

Abstract Details

Activity Number: 170 - SPEED: Biopharmaceutical Methods and Application I, Part 1
Type: Contributed
Date/Time: Monday, July 29, 2019 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract #304562 Presentation
Title: Evaluating the “One-Model Fits All” Approach for Modeling Clinical Trial Adverse Events
Author(s): Stephanie Pan*
Companies:
Keywords: adverse event; count data; overdispersion
Abstract:

Often, adverse events (AE) are summarized as counts and rates per patient time-at-risk. In comparing AE rates between treatment groups, typically the same distributional assumption is applied across all AEs with study protocols specifying the same modeling approach for each AE class despite known differences in dispersion. Using data from a randomized, 2-arm trial evaluating an experimental therapy in advanced heart failure patients, we evaluated differences in performance and fit of Poisson, negative binomial (NB), Poisson Inverse-Gaussian (PIG), zero-inflated Poisson (ZIP), zero-inflated negative binomial (ZINB), Poisson hurdle (PH), and negative binomial hurdle (NBH) models across various AE types. Model estimates, fit, and performance were assessed using repeated sub-sampling cross-validation. For AEs with mild overdispersion, model validation mean square error (MSE) was reasonable and similar across all models. Conversely, AEs with high overdispersion had high MSE across all models; NB, PIG and ZINB models had similar standard error (SE) estimates and better fit compared to Poisson models. Our results indicate a “one-model fits all” approach is likely inadequate.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2019 program